Axomove
Description
Axomove is a digital clinic promoting adapted physical activity as a non-drug therapy combined with remote monitoring for preventing and rehabilitating osteoarticular disorders.
Currently in its second round of fundraising, Axomove is looking for €3 million in financing to accelerate its growth as the first rehab super-app combining digital therapy and remote monitoring.
In a nutshell :
- Axomove aims at preventing, rehabilitating and monitoring musculoskeletal disorders via a Software as Medical Device (SaMD), combining digital therapy and personalized support from healthcare professionals.
- In the prevention market, Axomove is generating B2B recurring revenues from companies such as Allianz, France TV, Air France, Eiffage, Coca Cola, Heineken,Intermarché.
- In the rehabilitation market, Axomove is generating B2B recurring revenues from some 50 public (CHU Lille, Bordeaux, Rennes, Nîmes etc.) and private (Ramsay, Orpéa, Elsan, Vyv etc.) rehab centers.
- Axomove is conducting a randomized controlled trial (RCT) and has submitted to the French Ministry of Health their application for the reimbursement of their solution as a digital medical device and expects an official reply in October.
